CHAPTER – 8

BIBLIOGRAPHY

273

8. BIBLIOGRAPHY

1. Gao F, Yue L, White AT, Pappas PG, Barchue J, Hanson AP,

Greene BM, Sharp PM, Shaw GM, Hahn BH. Nature 1992;358

(6386):495-499.

2. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael

SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM,

Hahn BH. Nature 1999;397(6718):436-441.

3. Lanao JM, Briones E, Colino CI. J Drug Target 2007;15:21-36.

4. Mirchandani H, Chien YW. Int J Pharm 1993;95:1-21.

5. Li XL, Chan WK. Adv Drug Deliv Rev 1999;39:81-103.

6. Ojewole E, Mackraj I, Naidoo P, Govender T. Eur J Pharm And

Biopharm 2008;70:697-710.

7. www.aidsinfor.nih.gov

8. Betty JD, In; Herfindal TE, Eds, Text Book of Therapeutics Drug

and Disease Management, 7th Edn., Lippincott Williams and

Wilkins, USA, 2000, pp1555.

9. Stephen R. David WH. In; Rall TW, Taylor P, Nies AS, Gilman AG.

Eds., Goodman and Gilman’s The Pharmacological Basis of

Therapeutics, 8th Edn, Vol. II, Pergamom Press Inc.,1991,pp1182.

10. De Clercq E. Med Res Reviews 2008;28(6):929-953.

11. Serajuddin ATM. J Pharm Sci 1999;88:1058-1066.

12. Leuner C, Dressman J. Eur J Pharm Biopharm 2000;50:47-60.

13. Loftsson T, Jarho P, Masson M, Jarvinen T. Expert Opin Drug Deliv

2005b;2(2):335-351.

274

14. Loftsson T, Duchene D. Int J Pharm 2007;329:1-11.

15. Noyes AA, Whitney WR. J Am Chem Soc 1897;19(12):930-934.

16. Hintz RJ, Johnson KC. Int J Pharm 1989;51:9-17.

17. Yalkowsky SH. “Techniques of Solubilization of Drugs” (Drugs and

the Pharmaceutical Sciences, Vol.12), Marcel Dekker Inc., New

York,1981.

18. Wadke DA, Serajuddin ATM, Jacobson H. Preformulation testing.

In: Lieberman HA, Lachman L, Schwartz JB, eds. Pharmaceutical

Dosage Forms: Tablets. New York, NY: Marcel Dekker;1989,pp1-73.

19. Stella VJ, Nti-Addae KW. Adv Drug Deliv Rev 2007;59:677-694.

20. Pinnamaneni S, Das NG, Das SK. Pharmazie 2002;57:291-300.

21. Serajuddin ATM. Adv Drug Deliv Rev 2007;59:603-616.

22. Sekiguchi K, Obi N. Chem Pharm Bull 1961;8:266.

23. Chiou WL, Riegelman S. J Pharm Sci 1971;60:1281-1302.

24. Corrigan OI. Drug Dev Ind Pharm 1985;11:697-724.

25. Ford JL. Pharm Acta Helv 1986; 61:69-88.

26. Goldberg AH, Gibaldi M, Kanig JL, Mayersohn M. J Pharm Sci

1966;55:581-583.

27. Serajuddin ATM. J Pharm Sci 1999;88(10);891-900.

28. Narang A, Shrivastava A. Drug Dev Ind Pharm 2002;26(8):111-

115.

29. Chokshi R, Hossein Z. Int J Pharm Res 2004;3:3-16.

30. Craig DQM. Int J Pharm 2002;231:131-144.

31. Breitenbach J. Eur J Pharm And Biopharm 2002;54:107-117.

32. Vasconcelos T, Sarmento B, Costa P. Drug Discovery Today 2007;

275

12(23-24):1068-1075.

33. Juppo AM, Boissier C, Khoo C. Int J Pharm 2003;250:385-401.

34. Coviello T, Matricardi P, Marianecci C, Alhaique F. J Control

Release 2007;119:5-24.

35. Robyt JF. Dextran. In: Mark HF, Bikales NM, Overberger CG,

Menges G, eds. Encyclopedia of Polymer Science and Engineering.

Vol. 4, New York, NY: John Wiley & Sons; 1986,pp752-767.

36. Hehre EJ. J Biol Chem 1956;222:739-750.

37. Takagi K, Ioroi R, Uchimura T, Kozaki M, Komagata K. J Ferment

Bioeng 1994;77:551-553.

38. Ruckel ER, Schuerch C. Chemical synthesis of a dextran model,

poly-α-(1,6)-anhydro-D-glucopyranose, in Biopolymers, Vol 5, ed

by Goodman M. Wiley, Chichester, 1967,pp515-523.

39. Virnik AD, Khomvakov KP, Skokova IF. Russ Chem Rev 1975;44:

588-602.

40. Naessens M, Cerdobbel A, Soetaert W, Vandamme EJ. J Chem

Technol Biotechnol 2005;80:845-860.

41. Dhaneshwar SS, Kandpal M, Gairola N, SS Kadam. Indian J

Pharm Sci 2006;68(6):705-714.

42. Mehvar R. J Control Release 2000;69:1-25.

43. Gil EC, Colarte AI, Bataille B, Pedraz JL, Heinamaki J. Int J

Pharm 2006;317:32-39.

44. Uekama K. Chem Pharm Bull 2004;52:900-915.

45. Irie T, Uekama K. J Pharm Sci 1997;86:147-162.

46. Loftsson T, Brewester M. J Pharm Sci 1996;85:1017-1025.

276

47. Simpi S, Chauhan B, Shimpi P. Acta Pharm 2005;55:139-156.

48. Brewester ME, Loftsson T. Adv Drug Deliv Rev 2007;59:645-666.

49. Arias MJ, Moyano JR, Gines JM. Int J Pharm 1997;153(2):181-

189.

50. Millic AJ, Rajic DS, Tasic Lj, Djuric S, Kasa P, Pintye HK. Drug

Dev Ind Pharm 1997;23(11):1123-1129.

51. Martin DB, Udupa N. Indian J Pharm Sci 1995;57(5):203-206.

52. Otero-Espinar FJ, Anguiano-Igea S, Garcia-Gonzalez N, Vila-Jato

JL , Blanco-Mendez J. Int J Pharm 1992;79(1-3):149-157.

53. Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P. Drug Dev Ind

Pharm 2005:31:697-707.

54. Sanghavi NM, Rajeshree M, Mushtaq F. Drug Dev Ind Pharm

1995;21(3):375-381.

55. Piel G, Pirotte B, Deleneuville I, Neven P, Llabres G, Delarge J ,

Delattre L. J Pharm Sci 1997;86:475-480.

56. Tayade P, RajendraKumar K. J Pharm Biomed Anal

2004;34(2):333-339.

57. Giovanni FP, Depalmo GA, Gaetana G , Sante M. Drug Dev Ind

Pharm 1997;23(1):27-37.

58. Szejtli J, Davies JED. Cyclodextrin technology. Edn. Kluwer

academic publishers, Dordrecht,1988.

59. Van Hees T, Piel G, Evrard B, Otte X, Thunus L, Delattre L. Pharm

Res 1999;16:1864-1870.

277

60. Van Hees T, Barillaro V, Piel G, Bertholet P, Henry De Hassonville

S, Evrard B, Delattre L. J Incl Phenom Macrocycl Chem 2002;44:

271-274.

61. Xianhong W, Fei T, Zhijun J, Ziuyang L. J Pharm Biomed Anal

2004;34:517–523.

62. George ZP , Bikiaris D, Karavas E, Politis S, Docoslis A, Park Y,

Stergiou A, Georgarakis E. AAPS J 2006;8(4):623-631.

63. Loftsson T, Masson M, Brewster ME. J Pharm Sci 2002;91(11):

2307-2316.

64. Andersen FM, Bundgaard H. Int J Pharm 1984;20:155-162.

65. Liu L, Guo QX. J Incl Phenom Macrocycl Chem 2002;42:1-14.

66. Davis ME, Brewster ME. Nature Reviews Drug Discovery 2004;

3:1023-1035.

67. Higuchi T, Connors KA. Adv Anal Chem Instrum 1965;4:117-212.

68. Loftsson T, Masson M, Brewster ME. J Pharm Sci 2004;93:1091-

1099.

69. Maria JAB, Moyano JR, Perez-Martinez JI , GinesJM. J Pharm

Biomed Anal 1998;18(1-2):275-279.

70. Zarzycki PK, Lamparczyk H. J Pharm Biomed Anal 1998;18(1-

2):165-170.

71. Giovanni FP, Pascal W, Andre S. Drug Dev Ind Pharm

1993;19(8):875-885.

72. Beatriz PV, Iliana PL, Magdalena EL, Patricia SP, Ernesto E, Juan

JTL. Eur J Pharm Sci 2001;13(3):325-331.

73. Loftsson T. Pharmazie 1998;3:733-740.

278

74. Tadakazu T, Masaki N, Yukl T, Kimio T, Masanori K, Yoshiharu M,

Tsuneji N. J Pharm Sci 1986;75(4):391-394.

75. Josef P, Teruhiko H. Int J Pharm 1992;80(1-3):243-247.

76. Thorsteinn L, Hafrun F. Int J Pharm 1998;163(1-2):115-121.

77. Loftsson T. J Incl Phenom Macrocycl Chem 2002;44:63-67.

78. Amidon GL, Lennernas H, Shah VP, Crison JR. Pharm Res

1995;12(3):413-420.

79. Rajewski RA, Stella VJ. J Pharm Sci 1996;85(11):1142-1169.

80. Ukema K. J Incl Phenom Macrocycl Chem 2002;44:3-7.

81. Rasheed A, Ashok Kumar CK, Sravanthi VVNS. Sci Pharm

2008;76:567-598.

82. Mishra PR, Namdeo A, Jain NK. Indian J Pharm Sci

1999;61(4):193-198.

83. Szejtli J. Med Res Reviews 1994;14(3):353-386.

84. Szejtli J. Chem Rev 1998;98(5):1743-1754.

85. Nelson M, Waters L, John L. Int J Clin Pract 2007;61(1):105-

118.

86. Kusum VD, Roopa SP. Indian J Pharm Sci 2006;68(1):1-6.

87. Antunes AMM, Duarte MP, Santos PP, Costa GG, Heinze TM,

Beland FA, Marques M. Chem Res Toxicol 2008;21:1443-1456.

88. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M,

Lennernal H, Hussain AS, Junginger HE, Stavchansky SA, Midha

KK, Shah VP, Amidon GL. Mol Pharm 2004;1(1):85-96.

89. Hawi A, Bell G. Pharm Res 1994;11(Suppl):236.

279

90. Lamson MJ, Sabo JP, MacGregor TR, Pav TW, Rowland L, Hawi A.

Biopharm Drug Dispos 1995;20:285-291.

91. Zakeri-Milani P, Barzegar-Jalali M, Azimi M, Valizadeh H. Eur J

Pharm Biopharm 2009;73:102-106.

92. Virnik AD, Khomvakov KP, Skokova IF. Russ Chem Rev 1975;44:

588-602.

93. Ling GN, Ochaenfeld MM, Walton C, Bersinger TJ. Physiol Chem

Phys 1980;12:1-3.

94. Ozeki T, Yuasa U, Kanaya Y. Int J Pharm 1997;155:209.

95. Aigner Z, Benz I, Kata M. J Incl Phenom 1995;20:241.

96. Roger AR, Valentino JS. J Pharm Sci 1996;85(11):1142-1169.

97. Stella VJ, Rajewski RA. Pharm Res 1997;14:556-567.

98. Byrn S, Pfeiffer R, Ganey M, Hoiberg C, Poochikial G. Pharm Res

1995;7:945-54.

99. Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. 2001. Survival

after AIDS diagnosis in adolescents and adults during the

treatment era, United States, 1994–1997. JAMA 285,1308-1315.

100. Mirchandani H, Chien YW. Int J Pharm 1993;95:1-21.

101. Uekama K, Otagiri M. Crit Rev Ther Drug Carrier Syst 1986;3:1-

40.

102. Janssens S, Van den MG. J Pharm Pharmacol 2009;61:1571-

1586.

103. Baert L, Elvire C, Verreck G. Antiretroviral compositions with

improved bioavailability, Eur. Patent, 0,872,233, 1997.

280

104. Kai T, Akiyama Y, Nomura S, Sato M. Chem Pharm Bull

1996;44:568-571.

105. Fawaz F, Bonini F, Guyot M, Bildet J, Maury M, Lagueny AM. Int

J Pharm 1996;132:271-275.

106. Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Todo S, Miyazaki K.

J Pharm Pharmacol 1999;51:159-164.

107. El-Zein H, Riad L, El-Bary AA. Int J Pharm 1998;168:209-220.

108. Nasongkla N, Wiedmann AF, Bruening A, Beman M, Ray D,

Bornmann WG, Boothman DA, Gao J. Pharm Res

2003;20(10),1626-1633.

109. Jafari MR, Danti AG, Ahmed I. Int J Pharm 1988;48:207-215.

110. Chowdary KPR, Ramesh VRNS. Indian J Pharm Sci 1994;56(3):

95-99.

111. Arias MJ, Gines JM, Moyano JR, Perez-Martlnez JI, Rabasco

AM.Int J Pharm 1995;123:25-31.

112. Chutimaworapan S, Ritthidej GC, Yonemochi E, Oguchi

T,Yamamoto K. Drug Dev Ind Pharm 2000;26(11):1141-1150.

113. Ozkan Y, Do anay N, Dikmen N, Imer AK. Il Farmaco

2000;55(67):433-438.

114. Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Eur J

Pharm Biopharm 2006;64:200-205.

115. Ahuja N, Katare OP, Singh B. 2007. Eur J Pharm Biopharm

2007;65:26–38.

116. Moneghini M, Bellich B, Baxa P, Princivalle F. Int J Pharm

2008;361:125-30.

281

117. Shah J, Vasanti S, Anroop B, Vyas H. J Incl Phenom Macrocycl

Chem 2009;63(1-2):69-75.

118. Joe JH, Lee WM, Park YJ, Joe KH, Oha DH, Seo YG, Jong Woo JS,

Yong CS, Choia HG. Int J Pharm 2010;395:161-166.

119. Khattab IS, Nada A, Zaghloul AA. Drug Dev Ind Pharm 2010;

36(8):893–902.

120. Redenti E, Szente L, Szejtli J. J Pharm Sci 2000;89(1):1-8.

121. Thompson DO. Crit Rev Ther Drug Carrier Syst 1997;14:1-104.

122. Rajeswari C, Ahuja A, Javed A, Khar RK. AAPS Pharm Sci Tech

2005;6(2):329-357.

123. Kedzierewicz F, Hoffman M, Maincent P. Int J Pharm 1990;58:

221-221.

124. Ahmed SM, Abdel-Rahman AA, Saleh SI, Ahmed MO. Int J Pharm

1993;96:5-11.

125. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Int J Pharm

1995;123:53-63.

126. Ozkan Y, Ataya T, Dikmena N, Isimera A, Aboul-Enein HY.

Pharma Acta Helv 2000;74:365-370.

127. Veiga F, Fernandes C, Maincent P. Drug Dev Ind Pharm

2001;27(6):523-532.

128. Pose-Vilarnovo B, Perdomo-Lopez I, Echezarreta-Lopeza M,

Schroth-Pardo P, Estrada E, Torres-Labandeira JJ. Eur J Pharm

Sci 2001;31:325-331.

129. Mura P, Teresa MT, Bettinetti GP. Eur J Pharma Sci 2001;13:

187-94.

282

130. Fernandes CM, Vieira MT, Veiga FJB. Eur J Pharm Sci 2002;15:

79-88.

131. Peeters J, Neeskens P, Tollenaere J, Remoortere PV, Brewstrer

ME. J Pharm Sci 2002;91(6):1414-1422.

132. Archontaki HA, Vertzoni MV, Athanassiou MMH. J Pharm Biomed

Anal 2002;28(3):761-769.

133. Wong JW, Yuen KH. Drug Dev Ind Pharm 2003;29(9):1035-1044.

134. Buchi Naidu N, Chowdary KPR, Murthy KVR, Satyanarayana V,

Hayman AR, Becket G. J Pharm Biomed Anal 2004;35(1):75-86.

135. Saetern AM, Nguyen NB, Bauer-Brandl A, Brandl M. Int J Pharm

2004;284:61-68.

136. Rawata S, Jain SK. Eur J Pharm Biopharm 2004;57:263-267.

137. Wen X, Tan F, Jing Z, Liu Z. J Pharm Biomed Anal 2004;34(3):

517-523.

138. Pralhad T, Rajendra KK. J Pharm Biomed Anal 2004;34(2):333-

339.

139. Ruan LP, Yu BY, Fu GM, Zhu DN. J Pharm Biomed Anal 2005;

38:457-464.

140. Chowdary KPR, Srinivas SV. AAPS Pharm Sci Tech 2006;7(3):E1-

E6.

141. Al Omari MM, Daraghmeh NH, El-Barghouthi MI, Zughul MB,

Chowdhry BZ, Leharne SA, Badwan AA. J Pharm Biomed Anal

2009;50:449-458.

142. Nicolescu C, Arama C, Monciu CM. Farmacia 2010;58(1):78-88.

283

143. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R,Augustijnsa

P, Van den Mootera G. Eur J Pharm Sci 2000;10:311-322.

144. Damian F, Blaton N, Dessern H, Clou V, Naesens L, Balzarini J,

Kinget R, Augustijns P, Van den Mooter G. J Pharm Pharmacol

2001;53:1109-1116.

145. Law D, Krill SL, Schmitt EA , Fort JJ, Qiu Y, Wang W, Porter WR. J

Pharm Sci 2001;90(8):1015-1025.

146. Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, Krill

AL, Qiu Y. J Pharm Sci 2004;93(3):563-570.

147. Goddeeris C, Van den Mooter G. Eur J Pharma Sci 2008;35:104-

113.

148. Mohammed GA, Vibha P, Arvind KB. Pharm Dev Technol 2008;

13:299-310.

149. Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den

Mooter G. Eur J Pharma Sci 2008;70:861-868.

150. Sanganwar GP, Sathigari S, Jayachandra Babu R, Gupta RB. Eur

J Pharm Sci 2010;39:164-74.

151. Ahire BR, Rane BR, Bakliwal SR, Pawar SP. Int J Pharm Tech Res

2010;2(3):2007-2015.

152. Ahmed SM, Abdel-Rahman AA, Saleh SI, Ahmed MO. Int J Pharm

1993;96:5-11.

153. Echezarreta-Lopeza M, Torres-Labandeiraa JJ, Castineiras-Seijoa

L, Santana-Peninb L, Vila-Jato JL. Eur J Pharm Sci 2000;9:381-

386.

284

154. Boudad H, Legrand P, Lebas G, Cheron M, Duchêne D, Ponchel G.

Int J Pharm 2001;218:113‐124.

155. Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Ramsey MG,

Ruble KM, Wacher VJ, Wempe MF. Biomacromolecules 2008;9:

305-313.

156. Yang H, Parniak MA, Isaacs CE, Hillier SL, Rohan LC. AAPS J

2008;10(4):606-613.

157. Sathigar S, Chadha G, Lee YHP, Wright N, Parsons DL, Rangari

VK, Fasina O, Babu RJ. AAPS Pharm Sci Tech 2009;10(1):81-87.

158. Pathak SM, Musmade P, Dengle S, Karthik A, Bhat K, Udupa N.

Eur J Pharm Sci 2010;41:440-451.

159. Nelson M, Waters L, John L. Int J Clin Pract 2007;61(1):105-118.

160. Murphy RL, Montaner J. Exp Opin Invest Drugs 1996;5(9):1183-

1199.

161. Indian Pharmacopoeia. (5th eds) Published by the controller of

publication, Delhi 2007;3:1433-1436.

162. Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI,

Stammers DK. Proc Natl Acad Sci USA 99;(22):14410-14415.

163. http://www.aidsinfo.nih.gov

164. http://www.rxlist.com

165. The Merck Index.; Merck & Co., Inc.: Whitehouse Station, N.J. 13

(6514):1163.

166. FDA Guidance for Industry: Waiver of In Vivo Bioavailability and

Bioequivalence Studies for Immediate-Release Solid Oral Dosage

285

Forms Based on a Biopharmaceutics Classification System

(August 2000).

167. Robyt JF, Dextran, in: H.F. Mark, N.M. Bikales, C.G. Overberger,

G. Menges (Eds.), Encyclopedia of Polymer Science and

Engineering, John Wiley & Sons, New York,1986,pp.752-767.

168. De Belder AN, Medical applications of dextran and its derivatives,

in Polysaccharides in Medicinal Applications, ed by Dumitriu S.

Marcel Dekker, New York, 1996,pp.505-523.

169. Larsen C. Adv Drug Deliv Rev 1989;3:103-154.

170. Anonymous, Dextran: 50 years—still going strong. Agro-Food-

Industry Hi-Tech March/April 1997;10-11.

171. Vandamme EJ, Renard CEFG, Arnaut FRJ, Vekemans NMF and

Tossut PPA, Process for obtaining improved structure build-up of

baked products. US Patent 6 399 119 (2002).

172. Vandamme EJ, Renard CEFG, Arnaut FRJ, Vekemans NMF and

Tossut PPA, Process for obtaining improved structure build-up of

baked products. European Patent, EP 0790003A1 (1997).

173. Food SCO, Opinion of the Scientific Committee on Food on a

Dextran Preparation, Produced Using Leuconostoc mesenteroides,

Saccharomyces cerevisiae and Lactobacillus spp, as a Novel Food

Ingredient in Bakery Products. European Commission, Health and

Consumer Protection Directorate-General, Brussels (2000).

174. Murphy PT, Whistler RL. Dextrans, in Industrial Gums.

Polysaccharides and Their Derivatives, 2nd edn, ed by Whistler RL

and BeMiller JN. Academic Press, New York, 1973pp.513–542.

286

175. Duchene D, Wouessidjewe D. Pharm Technol 1990;14(6):26-34.

176. Duchene D, Wouessidjewe D. Pharm Technol 1990;4(8):22-30.

177. FDA Website (http://www.fda.gov/)

178. Duchene D, Wouessidjewe D. Drug Dev Ind Pharm 1990;16:2487-

2499.

179. Thomson DO. Crit Rev Ther Drug Carr Sys 1997;14:1-104.

180. Szente L, Szejtli J. Adv Drug Deliv Rev 1999;36:17-38.

181. Brewster ME, Bodor N. Parenteral safety and uses of 2-

hydroxypropyl-β-cyclodextrin. In Duchene D. (Ed.), Minutes of the

5th International Symposium on Cyclodextrins, Editions de Sante,

Paris,1990,pp.525-534.

182. Davis ME, Brewster ME. Nat Rev Drug Discov 2004;3:1023-1035.

183. Ford JL, Stewart AF, Dubois JL. Int J Pharm 1986;28:11-22.

184. Mura P, Manderioli A, Brananti G, Ceccarelli L. Drug Dev Ind

Pharm 1996;22:909-916.

185. Ford JL, Timmins P. Phamaceutical Thermal Analysis, Techniques

and Applications. Ellis Horwood, Chichester,1989.pp 108-135.

186. Cassel B, Twombly B. Rapid DSC determination of polymer

crystallinity, Am. Lab (Jan. 1998) 24-27.

187. Yu L. Adv Drug Delivery Rev 2001;48:27-42.

188. Jr Grangeiro S, Strattmann RR, Alburquerque MM, Araujo AAS,

Matos JR, Rolim Neto PJ. Acta Farm Bonaerense 2006;25(1):76-

82.

189. Khan KA. J Pharm Pharmacol. 1975;27:48-49.

287

190. Nakai Y, Yamamoto K, Terada K, Honbe HJ. J Incl Phenom Mol

Recognit Chem 1984;2:523-531.

191. Cabral Marues H, Hadgraft J, Kllaway I. Int J Pharm

1990;63:259-266.

192. Moyano J, Arias-Blanco M, Gines J, Giordano F. Int J Pharm

1997;148:211-217.

288